All Type of News
Novartis to give prior notice for domestic introduction of Entresto
‘Entresto,’ a Novartis’s new cardiac insufficiency drug, will be introduced in Korea.
According to the industry concerned on the 16th, Novartis has applied for the domestic approval of Entresto, a valsartan+sacubitri...
9 times different medical expenses for conscious sedation gastrointestinal endoscopy and colonoscopy
Large hospitals’ medical expenses for conscious sedation gastrointestinal endoscopy and colonoscopy make 9 times differences at the maximum depending on hospitals in Korea. The inexpensive ones are approximately KRW 3...
Total 18 patent cases of removals from ‘Green List’
As a part of registered patents of well-known pharmaceutical products are nullified, it was known that they were removed from the ‘Green List.’
According to the Ministry of Food and Drug Safety on the 14th, they were...
Chong Kun Dang successful in patent challenge for AvodartAs successful in the patent challenge for the prostatic and alopecia treatment, ‘Avodart(dutasteride, GSK),’ Chong Kun Dang raised a chance to launch its follow-up drug on its o...
|
Will Yuhan and Gilead cooperate for the hepatitis C drug, ‘Sovaldi’?The alliance of Gilead and Yuhan Corporation, which has shown the perfect match in the hepatitis B market, has attracted attention for possibility to keep the trend in the hepat...
|
Flu vaccines thrown away became a topic at National Assembly again
It was indicated at the National Inspection that flu vaccines for thousands of people have been thrown away every year. Even though vaccines worth of billions of wons have been dumped on a street, the government has l...
Selling prices of Cialis generics are 1/10 of the original
Competition has been fierce to occupy the generic market of ‘Cialisa’ a tadalafil-type impotency treatment, since its patent expiration on the last 4th.
157 generic products of Cialis were approved and launched in 60...
Getting close to KRW 200 billion in the Alzheimer’s dementia treatment market
The amount of laxatives for Alzheimer’s dementia symptoms has been annually increased by double figures. The last year’s prescriptions are expected to form a KRW 200 billion market soon as exceeding KRW 180 billion pr...
Pros and cons of Dong-A ST’s Baraclude generic early launchDespite existence of the substance patent, Dong-A ST launched a Baraclude generic on the 7th, giving various explanations in the industry. The explanations are divided into two ...
|
Price of Gilead’s Sovaldi expected at KRW 30 million in negotiation
The company seems to drop greediness. It was observed that Gilead will decide the price of ‘Sovaldi,’ a hepatitis C treatment approved domestically on the last 10th, at a lower price than the ones in other countries.
...
